ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MicroRNA-186-5p downregulation inhibits osteoarthritis development by targeting MAPK1

Li, Qing; Wu, Mingjie; Fang, Guofang; Li, Kuangwen; Cui, Wengang; Li, Liang; Li, Xia*; Wang, Junsheng*; Cang, Yanhong南方医科大学
Molecular Medicine Reports2021-4DOI: 10.3892/mmr.2021.11892
9被引7阅读
引用收藏
分享

摘要

As a chronic degenerative joint disease, the characteristics of osteoarthritis (OA) are degeneration of articular cartilage, subchondral bone sclerosis and bone hyperplasia. It has been reported that microRNA (miR)-186-5p serves a key role in the development of various tumors, such as osteosarcoma, non-small-cell lung cancer cells, glioma and colorectal cancer. The present study aimed to investigate the effect of miR-186-5p in OA. Different concentrations of IL-1 beta were used to treat the human chondrocyte cell line CHON-001 to simulate inflammation, and CHON-001 cell injury was assessed by detecting cell viability, apoptosis, caspase-3 activity and the levels of TNF-alpha, IL-8 and IL-6. Subsequently, reverse transcription-quantitative PCR was performed to measure miR-186-5p expression. The results demonstrated that following IL-1 beta treatment, CHON-001 cell viability was suppressed, apoptosis was promoted, the caspase-3 activity was significantly enhanced and the release of TNF-alpha, IL-8 and IL-6 was increased. In addition, IL-1 beta treatment significantly upregulated miR-186-5p expression in CHON-001 cells. It was also identified that MAPK1 was a target gene of miR-186-5p, and was negatively regulated by miR-186-5p. miR-186 inhibitor and MAPK1-small interfering RNA (siRNA) were transfected into CHON-001 cells to investigate the effect of miR-186-5p on CHON-001 cell injury induced by IL-1 beta. The results demonstrated that miR-186 inhibitor suppressed the effects of IL-1 beta on CHON-001 cells, and these effects were reversed by MAPK1-siRNA. In conclusion, the present results indicated that miR-186-5p could attenuate IL-1 beta-induced chondrocyte inflammation damage by increasing MAPK1 expression, suggesting that miR-186-5p may be used as a potential therapeutic target for OA.

学科与关键词

关键词
osteoarthritismicroRNA-186-5pinflammatory injurychondrocytes
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Molecular Medicine Reports
发表日期
2021-04
卷期
第 23 卷, 第 4 期
页码
253
DOI
10.3892/mmr.2021.11892
语言
ENGLISH
期刊收录
NSL
期刊等级
4区
成果收录
SCIE
资助标注
Sanming Project of Medicine in Shenzhen [SZSM201612019]; Shenzhen Key Laboratory of Digital Surgical Printing Project [ZDSYS201707311542415]; Southern Medical University Clinical Start-up Fund [LC2016ZD036]

作者

  • L

    Li, Qing (第一作者)

    southern med univ

  • W

    Wu, Mingjie

    southern med univ

查看全部 9 位作者收起作者
  • F

    Fang, Guofang

    southern med univ

  • L

    Li, Kuangwen

    southern med univ

  • C

    Cui, Wengang

    southern med univ

  • L

    Li, Liang

    southern med univ

  • L

    Li, Xia (通讯)

  • W

    Wang, Junsheng (通讯)

  • C

    Cang, Yanhong

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417